Diabetes

By Jonah Comstock 01:26 pm March 11, 2019
At SXSW in Austin this weekend, consumer genomics company 23andMe unveiled its latest test, a predisposition report on Type 2 diabetes. The test, which has not undergone FDA clearance and does not purport to diagnose a condition, is designed to help people understand when they’re at a higher-than-normal risk for Type 2 diabetes so they can alter their lifestyle. To assist with the latter piece,...
By Laura Lovett 01:39 pm March 5, 2019
This morning Senseonics, an implantable glucose sensor company, announced that data from its Eversense continuous glucose monitor will be integrated into the Glooko diabetes management platform.  This means that users of the Eversense CGM and app will now be able to sync it with the Glooko online platform and app, and be able to see historical blood glucose-related data as well as get updates...
By Laura Lovett 02:45 pm February 28, 2019
For folks managing their diabetes with Dexcom, Siri can now answer one more question: What is my glucose level? This morning Dexcom announced a slew of new companion app features for the Dexcom G6 continuous glucose monitoring system, including the ability for Siri to read a user’s glucose level out loud and display graphs directly on the lock screen.  The app, which was released in 2018, will...
By Dave Muoio 12:10 pm February 25, 2019
Earlier this month, Hygieia’s d-Nav Insulin Guidance Service — an app that titrates insulin doses for individual Type 2 diabetes patients, regardless of their regimen type — received 510(k) clearance from the FDA. The cloud-based service leverages proprietary algorithms, users’ individual blood glucose data and a small team of in-house health professionals to generate and deliver insulin dosage...
Novo Nordisk insulin pens
By Jonah Comstock 11:04 am February 20, 2019
Novo Nordisk’s connected insulin pens will integrate with the Abbott Freestyle Libre system, allowing Freestyle Libre users to see data about their insulin alongside their glucose readings, the companies announced this morning. "Lack of reliable information is a cause of huge frustration for many people with diabetes and their doctors," Anders Dyhr Toft, CVP of commercial innovation at Novo...
By Laura Lovett 04:23 pm February 18, 2019
This morning diabetes data management company Glooko announced that two soon-to-be released Novo Nordisk connected insulin pens will now be connected to the former’s diasend platform. The connected pens are expected to launch in early 2019, and will include Novo Nordisk’s NovoPen 6 and NovoPen Echo Plus. As part of today’s announcement Glooko also revealed a new compatibility feature for the ...
By Jonah Comstock 10:57 am February 11, 2019
Before we can solve the problems of patient engagement, we have to make sure we’re not the ones creating them. That was one takeaway of Geisinger CIO Karen Murphy’s remarks at the HIMSS Patient Engagement and Experience Summit in Orlando this morning. “We’re trying to innovate because […] patient engagement and patient experience is truly not ideal,” she said. “We have the system arranged so that...
By Laura Lovett 04:12 pm January 31, 2019
This morning diabetes self-management company One Drop announced its platform’s integration with Apple’s Health Records. As part of the integration patients who use the One Drop | Experts are able to share their EHRs with their personal diabetes coach. This gives patients the ability to share their vitals, lab results and medication history with One Drop coaches.  This news coincides with the...
By Dave Muoio 03:32 pm January 28, 2019
A recent paper published in Diabetes Technology & Therapeutics describes the design, safety and basic efficacy of a device-agnostic smartphone app that can interface with continuous glucose monitors, insulin pump devices and dosing algorithms from various manufacturers. Run on an unlocked smartphone, the interoperable Artificial Pancreas System (iAPS) smartphone app was reliable and generally...
By Jonah Comstock 01:45 pm January 8, 2019
Ascensia Diabetes Care, the Swiss tech company originally formed a few years ago from a merger of Bayer Health’s diabetes division and Panasonic Healthcare, is officially moving into the CGM space via a partnership with Huzhou, China-based Zhejiang POCTech. In the short term, the partnership will put an Ascensia-branded version of POCTech’s CE-Marked CGM in several markets by the end of the year...